Acumen Pharmaceuticals, Inc. (ABOS) vs NRx Pharmaceuticals, Inc. (NRXP)
- Acumen Pharmaceuticals, Inc. ABOS 1.69 +1.20%
- NRx Pharmaceuticals, Inc. NRXP 2.60 −4.06%
Acumen Pharmaceuticals, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($120.8M and $117.3M). Acumen Pharmaceuticals, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, NRx Pharmaceuticals, Inc. leads on 9 and Acumen Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ABOS | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 46.64% | 65.16% |
| Operating margin | 0.00% | (586.15%) | 0.00% |
| Net margin | 0.00% | (691.78%) | 0.00% |
| Free cash flow margin | 0.00% | (609.02%) | 0.00% |
| Return on equity | (120.50%) | 131.22% | (56.36%) |
| Return on assets | (72.97%) | (120.41%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack